A twin-column periodic countercurrent capture process that combines an efficient sequential, countercurrent loading process with a minimal twin-column hardware configuration is described.
The authors explain why Catalent decided to transition from stainless steel to single-use systems.
A new downstream purification platform using a salt-tolerant membrane adsorber.
He potential for frustration, time-wasting, and bad feelings between pharma and biotech partners is enormous. That some successful decisions are made under these circumstances is something of a miracle.
The authors explain why Catalent decided to transition from stainless steel to single-use systems.
The move to single-use manufacturing has prompted a paradigm shift in facility design.
More than half the deals made by pharma are with companies based in the US, 28 percent in Europe, and 15 percent Japan.
Quality control for disposable-bags
The authors describe the growth characteristics of human mesenchymal stem cells cultured in a stirred-tank bioreactor.
An integrated focus on product design, development, operation, and control.
Quality control for disposable-bags
*** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021***
A simple, sensitive, and universal platform for identification and quantification of trace-level protein impurities in biotherapeutics is described.
Aggregate formation is influenced by multiple aspects of the bioproduction process but can be mitigated by good process design and control.
USP's focus in 2013 involves standards relating to organic impurities, measurement of residual DNA and host-cell proteins in biotechnology products, and elemental impurities.
USP's focus in 2013 involves standards relating to organic impurities, measurement of residual DNA and host-cell proteins in biotechnology products, and elemental impurities.
An analytical method assesses the effects of media condition on cultured antibodies.
Traditional project decision-making vs. a QbD approach.
The author examines the use of closures for products intended for injection.
A twin-column periodic countercurrent capture process that combines an efficient sequential, countercurrent loading process with a minimal twin-column hardware configuration is described.
Establishing bioequivalence is difficult for drugs with high inter-subject variability or strong dependence on the physiological state of the gut.
An integrated focus on product design, development, operation, and control.
A UC Berkeley survey provides insight into biopharma's risk concerns and strategies.